Skip to Main ContentSkip to Footer

Jeffrey P. Zwerner MD, PhD

Assistant Professor of Dermatology
Insurance Plans Accepted

Areas of Expertise

  • Complex Medical Dermatology
  • Cutaneous T-Cell Lymphoma
  • Dermatology
  • Dermatopathology
  • General Adult Dermatology
  • Melanoma
  • Non-Melanoma Skin Cancer

Locations

Vanderbilt Dermatology
Vanderbilt Health One Hundred Oaks
719 Thompson Lane, Suite 26300
Nashville, TN 37204
Vanderbilt Dermatology Shelbyville
2839 Highway 231 North, Suite 209
Shelbyville, TN 37160

Education

  • Doctor of Medicine - University of Alabama at Birmingham, 2004
  • Doctor of Philosophy - University of Alabama at Birmingham, 2004
  • Internship - University of Alabama at Birmingham Health System, 2005
  • Residency - Stanford University Medical Center, 2008
  • Fellowship - Stanford University Medical Center, 2010

Board Certifications

  • Dermatology - American Board of Dermatology, 2008
  • Dermatopathology - American Board of Dermatology, 2010

Patient Comments

Patient Comments are gathered from the Press Ganey Patient Experience Survey and displayed in full. Patients are not identified in order to respect patient privacy.
I drive over an hour to see Dr Z. He listens to my concerns and is thorough in his exam. He explains what he finds
October 3, 2024
quote icon
No worries
October 2, 2024
quote icon
Great Experience
September 23, 2024
quote icon
Great Experience with Dr. Zwerner
September 22, 2024
quote icon
Dr zwerner is great.
September 12, 2024
quote icon
We love our doctor. He's efficient, personable, and most of all excellent at his profession.
September 11, 2024
quote icon
I had a sense that he was a bit rushed/multitasking as a result of too many patient's and not enough time in a day.
September 10, 2024
quote icon
Dr Zwerner listens & answers all my questions with professionalism & compassion
September 7, 2024
quote icon
Dr. Zwerner seemed to recognize me even though I hadn't been there in two years. He knew about my concerns and offered clear explanations and alternative treatment options
September 5, 2024
quote icon